FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:933-938 March 27, 1997 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Despite impressive advances in the safety of the blood supply,¹ the search for therapeutic alternatives to blood continues.^2,3 Erythropoietin (along with iron, vitamin B₁₂, and folic acid) has been recommended as a specific medication "that should be used instead of blood transfusion if the clinical condition of the patient permits sufficient time for these agents to promote erythropoiesis."⁴ Therapy with recombinant human erythropoietin (Epogen, Amgen, Thousand Oaks, Calif.) was first shown to correct the anemia caused by chronic renal failure in patients undergoing dialysis.⁵ Subsequently, erythropoietin (Procrit, OrthoBiotech, Raritan, N.J.) was also approved for the treatment of anemia caused . . . [Full Text of this Article]

Facilitating the Procurement of Autologous Blood

Erythropoietin

Acute Normovolemic Hemodilution

Combination Therapy

Stimulation of Erythropoiesis without Autologous Blood Donation

Dosage and Cost of Erythropoietin

Improving Cost Effectiveness

Predicting Perioperative Blood Requirements

Conclusions

Source Information

From the Departments of Medicine and Pathology (L.T.G.), Anesthesia (T.G.M.), and Surgery (G.L.A.), Washington University School of Medicine, St. Louis.

Address reprint requests to Dr. Goodnough at the Division of Laboratory Medicine, Box 8118, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110.

References

This article has been cited by other articles:

• Foley, R. N., Curtis, B. M., Parfrey, P. S. (2008). Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disease Receiving Erythropoietin Therapy. CJASN 3: 1669-1675 [Abstract] [Full Text]  
• Bayam, L., Tait, W. F., Macartney, I. D. (2007). Successful Repair of a Giant Abdominal Aortoiliac Aneurysm in a Jehovah's Witness. VASC ENDOVASCULAR SURG 41: 460-462 [Abstract]  
• Goodnough, L. T., Shander, A., Spivak, J. L., Waters, J. H., Friedman, A. J., Carson, J. L., Keating, E. M., Maddox, T., Spence, R. (2005). Detection, Evaluation, and Management of Anemia in the Elective Surgical Patient. Anesth. Analg. 101: 1858-1861 [Abstract] [Full Text]  
• Karkouti, K., McCluskey, S. A., Evans, L., Mahomed, N., Ghannam, M., Davey, R. (2005). Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery: [Le traitement a l'erythropoietine reduit efficacement les transfusions de culots globulaires en chirurgie orthopedique]. Canadian J. Anesthesia 52: 362-368 [Abstract] [Full Text]  
• Rosencher, N., Poisson, D., Albi, A., Aperce, M., Barre, J., Samama, C. M. (2005). Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery: [Deux injections d'erythropoietine corrigent une anemie moderee chez la plupart des patients en attente d'une operation orthopedique]. Canadian J. Anesthesia 52: 160-165 [Abstract] [Full Text]  
• Wagner, L. M., Billups, C. A., Furman, W. L., Rao, B. N., Santana, V. M. (2004). Combined Use of Erythropoietin and Granulocyte Colony-Stimulating Factor Does Not Decrease Blood Transfusion Requirements During Induction Therapy for High-Risk Neuroblastoma: A Randomized Controlled Trial. JCO 22: 1886-1893 [Abstract] [Full Text]  
• Taffe, P., Burnand, B., Wietlisbach, V., Vader, J.-P. (2004). Influence of Clinical and Economical Factors on the Expert Rating of Appropriateness of Preoperative Use of Recombinant Erythropoietin in Elective Orthopedic Surgery Patients. Med Decis Making 24: 122-130 [Abstract]  
• Leigh-Smith, S (2004). Blood boosting. Br. J. Sports. Med. 38: 99-101 [Abstract] [Full Text]  
• Mancini, D. M., Katz, S. D., Lang, C. C., LaManca, J., Hudaihed, A., Androne, A.-S. (2003). Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure. Circulation 107: 294-299 [Abstract] [Full Text]  
• Sonzogni, V., Crupi, G., Poma, R., Annechino, F., Ferri, F., Filisetti, P., Bellavita, P. (2001). Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery. Br J Anaesth 87: 429-434 [Abstract] [Full Text]  
• Seidenfeld, J., Piper, M., Flamm, C., Hasselblad, V., Armitage, J. O., Bennett, C. L., Gordon, M. S., Lichtin, A. E., Wade, J. L. III, Woolf, S., Aronson, N. (2001). Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials. JNCI J Natl Cancer Inst 93: 1204-1214 [Abstract] [Full Text]  
• Feagan, B. G., Wong, C. J., Kirkley, A., Johnston, D.W.C., Smith, F. C., Whitsitt, P., Wheeler, S. L., Lau, C. Y. (2000). Erythropoietin with Iron Supplementation To Prevent Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty: A Randomized, Controlled Trial. ANN INTERN MED 133: 845-854 [Abstract] [Full Text]  
• Goodnough, L. T., Skikne, B., Brugnara, C. (2000). Erythropoietin, iron, and erythropoiesis. Blood 96: 823-833 [Abstract] [Full Text]  
• Corwin, E. J. (2000). Understanding Cytokines Part I: Physiology and Mechanism of Action. Biol Res Nurs 2: 30-40 [Abstract]  
• Baldry, C., Backman, S.B., Metrakos, P., Tchervenkov, J., Barkun, J., Moore, A. (2000). Liver transplantation in a Jehovah's Witness with ankylosing spondylitis. Canadian J. Anesthesia 47: 642-646 [Abstract] [Full Text]  
• Hardy, J.-F., Harel, F., Belisle, S. (2000). Transfusions in patients undergoing cardiac surgery with autologous blood. Canadian J. Anesthesia 47: 705-711 [Abstract] [Full Text]  
• Stohlawetz, P. J., Dzirlo, L., Hergovich, N., Lackner, E., Mensik, C., Eichler, H. G., Kabrna, E., Geissler, K., Jilma, B. (2000). Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 95: 2983-2989 [Abstract] [Full Text]  
• Urayama, H., Ohtake, H., Tawaraya, K., Watanabe, Y. (2000). Autologous Blood Donation with Erythropoietin in Abdominal Aortic Aneurysm Repair: Special Reference to Blood Pressure and Hormonal Changes. VASC ENDOVASCULAR SURG 34: 157-162 [Abstract]  
• Rizzuto, G., Cappelletti, M., Maione, D., Savino, R., Lazzaro, D., Costa, P., Mathiesen, I., Cortese, R., Ciliberto, G., Laufer, R., La Monica, N., Fattori, E. (1999). Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl. Acad. Sci. USA 96: 6417-6422 [Abstract] [Full Text]  
• Kost, G. J., Ehrmeyer, S. S., Chernow, B., Winkelman, J. W., Zaloga, G. P., Dellinger, R. P., Shirey, T. (1999). The Laboratory-Clinical Interface: Point-of-Care Testing. Chest 115: 1140-1154 [Abstract] [Full Text]  
• Scott, M. G., Kucik, D. F., Goodnough, L. T., Monk, T. G. (1997). Blood substitutes: evolution and future applications. Clin. Chem. 43: 1724-1731 [Abstract] [Full Text]